Eligibility criteria are broad
The vision loss MDL involves allegations concerning GLP-1 medications used for type 2 diabetes and chronic weight management, including Ozempic, Wegovy, Saxenda, and Trulicity
One Medical doesnt offer structured nutrition coaching, lifestyle guidance, or a dedicated weight-loss program, so patients who want hands-on support may find it less comprehensive than GLP-1focused clinics
A spokesperson for Blue Cross told Newsweek the decision came after "careful consideration of GLP-1 weight loss drugs' efficacy, safety and access, and cost." They did not expand on what these concerns were, but research published by the insurer in May found that "most people are unlikely to see lasting benefits" from weight-loss medication
Some scientists even call Alzheimers type 3 diabetes because of this energy problem